Core Viewpoint - Milestone Scientific Inc. announces the retirement of CEO Arjan Haverhals effective December 31, 2024, while he will continue to serve as a director and consultant to support the leadership transition [1][2]. Leadership Transition - Neal Goldman, Chairman of the Board, will assume the role of Interim CEO following Haverhals' departure, with the Board actively seeking a permanent CEO to lead the company’s growth and commercialization efforts for the CompuFlo® Epidural System [3][4]. CEO Contributions - Haverhals has had a distinguished career of over 30 years in the medical device and pharmaceutical industries, contributing significantly to the financial and operational stability of Milestone Scientific [2][5]. - Under his leadership, the company achieved a granted Medicare Part B Physician payment rate for the CompuFlo® Epidural System, which is a significant milestone for its commercialization [5]. Company Overview - Milestone Scientific Inc. focuses on developing innovative injection technologies aimed at enhancing patient comfort and safety through its proprietary DPS Dynamic Pressure Sensing Technology® [6].

ROSELAND, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Friday, November 15th, 2024, to discuss the company’s financial results for the third quarter ended September 30, 2024, as well as the company’s corporate progress and other developments. The conference call will be available via telep ...

ROSELAND, N.J., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that iHeal Pain Center has adopted the CompuFlo® Epidural System following successful epidural steroid injection (ESI) procedures by Dr. Desai, DO. Dr. Desai has performed six cervical and two lumbar ESI procedures using the CompuFlo® Epidural System, leading to its integration within the clinic. ...

Secured Medicare price assignment for the CompuFlo® Epidural System in multiple U.S. states Gross margin for the second quarter of 2024 increased to 76.1% from 65.0% for the same period last year driven by an increase in U.S. e-commerce sales ROSELAND, N.J., Aug. 15, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provides a business update and reported financial results for the ...

ROSELAND, N.J., Aug. 12, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Thursday, August 15th, 2024, to discuss the company's financial results for the second quarter ended June 30, 2024, as well as the company's corporate progress and other developments. The conference call will be available via telephone ...

Core Insights - Milestone Scientific Inc. has announced a strategic partnership with Axial Biologics to distribute its CompuFlo® Epidural System in New Jersey, Texas, and Florida [1][2] - The partnership follows the granting of a Medicare Part B Physician payment rate for the CompuFlo® Epidural System, which is expected to enhance access and adoption within the pain management community, particularly for Medicare patients [2][3] - The CompuFlo® Epidural System is designed to provide precise identification of the epidural space, reducing complications associated with traditional methods, and the recent Medicare Price Assignment is anticipated to facilitate broader adoption across the U.S. [3] Company Overview - Milestone Scientific Inc. focuses on developing innovative injection technologies and instruments for medical and dental applications, utilizing its proprietary DPS Dynamic Pressure Sensing Technology® [5] - Axial Biologics specializes in research and development of regenerative medicine solutions, aiming to enhance patient healing and quality of life [4]

ROSELAND, N.J., July 30, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced receipt of multiple Notices of Allowance (NOA) for essential patent applications in both the U.S. and Europe. One NOA was granted by the U.S. Patent and Trademark Office and one NOA was granted by the European Patent Office for a new patent titled "Device and Method for Needle/Catheter Location Uti ...

ROSELAND, N.J., July 23, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that Novitas Solutions, Inc. (Novitas), a Jurisdictional Medicare Administrative Contractor (JMAC), has granted a Medicare Part B Physician payment rate for the Company's CompuFlo® Epidural System under the American Medical Association's (AMA) technology-specific Category III CPT® code CPT0777T (r ...

Brazil is the 9th largest economy in the world with more than 21 million people suffering from chronic back pain An estimated 4-5 million epidural anesthesia procedures are performed annually in Brazil; potential to expand this addressable market due to CompuFlo's technological advantages Arjan Haverhals, CEO and President of Milestone Scientific, stated, "We are thrilled to bring the CompuFlo® Epidural System to Brazil, the 9th largest economy in the world, with a population of more than 200 million people ...

An estimated 4-5 million epidural anesthesia procedures are performed annually in Brazil; potential to expand this addressable market due to CompuFlo's technological advantages The CompuFlo® Epidural System, known for its ability to significantly reduce the morbidity and discomfort associated with traditional epidural procedures, uses the Company's patented Dynamic Pressure Sensing® technology. This real-time feedback technology ensures accurate placement and verification of the epidural needle in the epidu ...